Phase 3 Trial of Domiciliary Humidification to Mitigate Acute Mucosal Toxicity During Radiation Therapy for Head-and-Neck Cancer: First Report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM Study
Andrew Macann(Auckland City Hospital), Hans Hockey, Sandro Porceddu(Peter MacCallum Cancer Centre), Melanie L. Bell(University of Colorado Health), Colin Tang(Calvary Mater Newcastle Hospital), Michael Penniment, Randall P. Morton(Auckland Institute of Studies), Michael Poulsen(Mater Health Services), Carol Fraser‐Browne(Auckland City Hospital), Chris Wratten(Calvary Mater Newcastle Hospital), K Hay(Auckland City Hospital), Tsien Fua(Peter MacCallum Cancer Centre), V. Thomson(Auckland City Hospital), Madeleine King(The University of Sydney), Chris Milross(Chris O’Brien Lifehouse), Hedley Krawitz(Auckland City Hospital)
International Journal of Radiation Oncology*Biology*Physics
February 9, 2014
Cited by 11
Related Papers
Prognostic Significance of [<sup>18</sup>F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
|Journal of Clinical Oncology|2006|543
The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancer
|Radiotherapy and Oncology|2005|258
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer
|Head & Neck|2004|257
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
|International Journal of Radiation Oncology*Biology*Physics|2020|211